Tepezza Social Media Ads

 Horizon Therapeutics Inc., the client, launched Tepezza (teprotumumab-trbw) in 2020, the first FDA-approved treatment for Thyroid Eye Disease (TED). Over 20,000 patients have been treated with Tepezza across over 2,500 sites of care.

Horizon needed a nimble design and creative partner with healthcare experience to produce social media ads supporting their product, Tepezza. Working closely with Tepezza’s brand team , we complete have produced over 20 campaigns in 1040×1040 and Story Sizes.